Using pericoronary fat attenuation to guide management after coronary interventions
This study explores the limitations of contemporary coronary intervention strategies and the role of coronary inflammation in the natural history of atherosclerosis.
Related Articles
Predictors of pacemaker implantation in aortic regurgitation patients treated with a dedicated transcatheter heart valve
Study on permanent pacemaker implantation rates and risk factors after transcatheter aortic valve implantation for aortic regurgitation using the JenaValve Trilogy System.
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programme
Comprehensive overview of interventional procedures and therapies in cardiology, including coronary, valvular, heart failure, peripheral, hypertension, and stroke interventions.
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programme
Comprehensive overview of interventional procedures and therapies in cardiology, including coronary, valvular, heart failure, peripheral, hypertension, and stroke interventions.
Letter: Completeness or complexity? A nuanced reflection on multivessel revascularisation
The study examines the impact of diverse trial designs and patient populations on the assessment of complete revascularization strategies in acute myocardial infarction with multivessel…
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
Find out more about this article on Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A…
Can a CT scan characterise and predict HALT evolution?
Study on hypoattenuated leaflet thickening (HALT) observed in TAVI patients and its association with clinical outcomes.
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial
The COMPARE STEMI ONE trial evaluates an abbreviated DAPT regimen and OCT-guided revascularization in STEMI patients undergoing PCI.
Design and rationale of PRAGUE-26: a multicentre, randomised trial of catheter-directed thrombolysis for intermediate-high risk acute pulmonary embolism
The PRAGUE-26 trial evaluates the clinical outcomes of catheter-directed thrombolysis versus standard anticoagulation in patients with intermediate-high risk acute pulmonary embolism.